Cite
APA Citation
Dickinson, L., Amin, J., Else, L., Boffito, M., Egan, D., Owen, A., Khoo, S., Back, D., Orrell, C., Clarke, A., Losso, M., Phanuphak, P., Carey, D., Cooper, D., Emery, S., & , (n.d.). pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study. Clinical pharmacology & therapeutics, 98(4), 406–416. http://access.bl.uk/ark:/81055/vdc_100048667947.0x000056